Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000950170-25-094572

Interim CFO sold 147 shares at $3.39 ($498)

  • Interim CFO acquired 374 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Firmani Lori Interim CFO 2025-07-03 Option exercise +374 839 D
Firmani Lori Interim CFO 2025-07-03 Sale −147 $3.39 $498 692 D
Derivatives
Firmani Lori Interim CFO 2025-07-03 Option exercise · Restricted Stock Units −374 1,100 D
Open-market sales · 147 sh · avg $3.39 · $498
Loading xslF345X05/ownership.xml…